Clinical Trial Update: Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from AstraZeneca reports symptom improvements in patients with gastroesophageal reflux disease; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Not disclosed

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 2 | Status: COMPLETED | Results posted: 2013-03-18